{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:31:16Z","timestamp":1774528276777,"version":"3.50.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>The study aimed to investigate the association between the risk of hepatocellular carcinoma and thiazolidinediones use among type 2 diabetic patients who had risk factors for hepatocellular carcinoma.<\/jats:p>\n            <jats:p>A population-based case-control study was performed using the database of the Taiwan National Health Insurance Program. The cases consisted of 23580 type 2 diabetic subjects aged 20 to 84 years with newly diagnosed hepatocellular carcinoma between 2000 and 2011. The sex- and age-matched controls consisted of 23580 randomly selected type 2 diabetic subjects without hepatocellular carcinoma between 2000 and 2011. Ever use of thiazolidinediones was defined as subjects who had at least 1 prescription of thiazolidinediones before the index date. Never use of thiazolidinediones was defined as subjects who did not have a prescription of thiazolidinediones before the index date. The odds ratio and 95% confidence interval for the association between hepatocellular carcinoma and cumulative duration of thiazolidinediones use was measured by a multivariable logistic regression model.<\/jats:p>\n            <jats:p>Among subjects with any 1 of the comorbidities including alcohol-related disease, cirrhosis, hepatitis B infection, hepatitis C infection, and other chronic hepatitis, a multivariable logistic regression model demonstrated that there was a negative association between hepatocellular carcinoma and every 1-year increase of cumulative duration of thiazolidinediones use (adjusted odds ratio 0.94, 95% confidence interval 0.92\u20130.97).<\/jats:p>\n            <jats:p>There was a negative association in a duration-dependent manner between the risk of hepatocellular carcinoma and thiazolidinediones use among type 2 diabetic patients who had risk factors for hepatocellular carcinoma.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000019833","type":"journal-article","created":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T05:51:19Z","timestamp":1587793879000},"page":"e19833","source":"Crossref","is-referenced-by-count":6,"title":["Association of hepatocellular carcinoma with thiazolidinediones use"],"prefix":"10.1097","volume":"99","author":[{"given":"Shih-Wei","family":"Lai","sequence":"first","affiliation":[{"name":"College of Medicine, China Medical University"},{"name":"Department of Family Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Li","family":"Lin","sequence":"additional","affiliation":[{"name":"College of Medicine, China Medical University"},{"name":"Management Office for Health Data, China Medical University Hospital, Taichung"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan-Fu","family":"Liao","sequence":"additional","affiliation":[{"name":"College of Medicine, Tzu Chi University, Hualien"},{"name":"Division of Hepatogastroenterology, Department of Internal Medicine, Taichung Tzu Chi Hospital, Taichung, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,4]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1097\/00007611-200295100-00017","article-title":"Thiazolidinediones: a review of their benefits and risks","volume":"95","author":"Ovalle","year":"2002","journal-title":"South Med J"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ejphar.2015.10.057","article-title":"Effects of thiazolidinediones on metabolism and cancer: relative influence of PPARgamma and IGF-1 signaling","volume":"768","author":"Mughal","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"36361","DOI":"10.1074\/jbc.M110.137661","article-title":"Thiazolidinediones up-regulate insulin-like growth factor-1 receptor via a peroxisome proliferator-activated receptor gamma-independent pathway","volume":"285","author":"Higashi","year":"2010","journal-title":"J Biol Chem"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00592-013-0504-8","article-title":"Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials","volume":"51","author":"Monami","year":"2014","journal-title":"Acta Diabetol"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/hep.25509","article-title":"Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus","volume":"55","author":"Chang","year":"2012","journal-title":"Hepatology"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/jcpt.12151","article-title":"Dose effect of thiazolidinedione on cancer risk in type 2 diabetes mellitus patients: a six-year population-based cohort study","volume":"39","author":"Lin","year":"2014","journal-title":"J Clin Pharm Ther"},{"key":"R7-20230915","first-page":"1606","article-title":"The role of thiazolidinediones in hepatocellular carcinoma risk reduction: a population-based cohort study in Taiwan","volume":"7","author":"Huang","year":"2017","journal-title":"Am J Cancer Res"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2337\/dc11-2197","article-title":"Use of thiazolidinediones and the risk of colorectal cancer in patients with diabetes: a nationwide, population-based, case-control study","volume":"36","author":"Chen","year":"2013","journal-title":"Diabetes Care"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/bcp.12306","article-title":"Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysis","volume":"78","author":"Turner","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1634\/theoncologist.2012-0302","article-title":"Cancer risk for patients using thiazolidinediones for type 2 diabetes: a meta-analysis","volume":"18","author":"Bosetti","year":"2013","journal-title":"Oncologist"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1503\/cmaj.112102","article-title":"Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis","volume":"184","author":"Colmers","year":"2012","journal-title":"CMAJ"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1023\/A:1023636619477","article-title":"Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan","volume":"14","author":"Wang","year":"2003","journal-title":"Cancer Causes Control"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ajg.2011.384","article-title":"Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study","volume":"107","author":"Lai","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"(Suppl 2)","key":"R15-20230915","first-page":"S101","article-title":"Hepatocellular carcinoma in Taiwan","volume":"37","author":"Chen","year":"2007","journal-title":"Hepatol Res"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1051\/bmdcn\/2017070317","article-title":"Fluvastatin use and risk of acute pancreatitis:a population-based case-control study in Taiwan","volume":"7","author":"Liao","year":"2017","journal-title":"Biomedicine-Taiwan"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"e4427","DOI":"10.1097\/MD.0000000000004427","article-title":"The association between biliary tract inflammation and risk of digestive system cancers: a population-based cohort study","volume":"95","author":"Tsai","year":"2016","journal-title":"Medicine"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"e692","DOI":"10.4088\/JCP.15m10038","article-title":"Association of selective serotonin reuptake inhibitor use and acute angle-closure glaucoma","volume":"77","author":"Chen","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3747\/pdi.2016.00313","article-title":"Risk of and fatality from acute pancreatitis in long-term hemodialysis and peritoneal dialysis patients","volume":"38","author":"Wang","year":"2018","journal-title":"Perit Dial Int"},{"key":"R21-20230915","first-page":"24","article-title":"Herpes zoster correlates with pyogenic liver abscesses in Taiwan","volume":"6","author":"Shen","year":"2016","journal-title":"Biomedicine-Taiwan"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00228-017-2256-9","article-title":"Correlation between proton pump inhibitors and risk of pyogenic liver abscess","volume":"73","author":"Lin","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1051\/bmdcn\/2017070104","article-title":"Etodolac and the risk of acute pancreatitis","volume":"7","author":"Liao","year":"2017","journal-title":"Biomedicine-Taiwan"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"e12842","DOI":"10.1097\/MD.0000000000012842","article-title":"Correlation of the tamoxifen use with the increased risk of deep vein thrombosis and pulmonary embolism in elderly women with breast cancer: a case-control study","volume":"97","author":"Lin","year":"2018","journal-title":"Medicine"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/ggi.13568","article-title":"Tamoxifen use correlates with increased risk of hip fractures in older women with breast cancer: a case-control study in Taiwan","volume":"19","author":"Hung","year":"2019","journal-title":"Geriatr Gerontol Int"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1111\/jgs.15474","article-title":"Association between proton pump inhibitor use and Alzheimer's disease in older adults","volume":"66","author":"Liao","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jhbp.331","article-title":"Atrial fibrillation associated with acute pancreatitis: a retrospective cohort study in Taiwan","volume":"23","author":"Lai","year":"2016","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"R28-20230915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1041610217000801","article-title":"Glaucoma may be a non-memory manifestation of Alzheimer's disease in older people","volume":"29","author":"Lai","year":"2017","journal-title":"Int Psychogeriatr"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:15:05Z","timestamp":1694823305000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019833"}},"subtitle":["A population-based case-control study"],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":26,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000019833","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}